Capnography Devices Market Overview
The global capnography devices market generated $384.2 million revenue in 2017 and is projected to witness a CAGR of 18.2% during the forecast period, on account of growing prevalence of respiratory diseases, technological advancements, and rising government initiatives.
GLOBAL CAPNOGRAPHY DEVICES, BY COMPONENT, $M (2014-2025)
On the basis of component, the capnography devices market has been categorized into original equipment manufacturer (OEM) modules and others, which primarily includes, sampling lines, sensors and airway adapters, and anaesthetic breathing circuits. OEM modules has been dominating this market and is expected to continue holding the largest share throughout the analysis period. This OEM modules category is further bifurcated into infrared sensors and others. Among these, infrared sensors held 23.4% share in the global capnography OEM modules market in 2017.
The various products available in the capnography devices market include hand-held, stand-alone and multi-parameter capnographs. Among these, hand-held capnographs occupied the largest share in this market, with 62.2% contribution in 2017. Hand-held devices give greater flexibility of use in different patient care settings, which has resulted in its increasing preference.
Side stream, main stream and micro stream are the various technologies used in these devices. The demand for capnographs based on micro stream technology is expected to observe fastest growth, at a CAGR of 19.7% during the forecast period. Unlike the broad infrared spectrum produced by a black body emitter, micro stream technology based capnographs create an infrared emission precisely matching the absorption spectrum of CO2.
Based on application, the capnography devices market has been classified into emergency medicine, critical care, procedural sedation, pain management and others. During the forecast period, the market is expected to witness the highest growth in the procedural sedation application area, with a CAGR of 19.5%. The growth of the market in this application is characterized by increasing number of surgical procedures being performed in various healthcare settings.
On the basis of end user, the market is expected to witness fastest growth from ambulatory care centers (ACCs), advancing at CAGR of 19.4% during the forecast period. This can be attributed to the fact that an increasing number of ACCs in developed regions prefer to use these devices over pulse oximeters.
Geographically, North America has been largest market for capnography devices, contributing 56.4% in 2017. The North American market is mainly driven by rising prevalence of respiratory conditions, presence of prominent market players manufacturing these devices in the region, presence of well-established healthcare facilities and high awareness among healthcare professionals.
Capnography Devices Market Dynamics
Rising prevalence of respiratory diseases is a key factor supporting the growth of the capnography devices market. The rise in prevalence of some of the respiratory illness, such as chronic obstructive pulmonary disease (COPD), pulmonary embolism, and asthma, that require intensive respiratory monitoring, is expected to drive the demand for capnography devices in coming years. As per the European COPD Coalition (ECC), in 2010, around 384 million people suffered from moderate to severe COPD in the world, and this number is anticipated to grow over the forecast period. Moreover, COPD is the only major cause of death, the incidence of which is increasing at a high rate.
According to the, “The Global Asthma Report 2014”, by Global Asthma Network (GAN), asthma affects nearly 335 million people worldwide. This factor drives the clinical urgency for incorporation of capnographs in extensive treatment regimens, thus fueling the market demand. The increasing need for capnography in emergency medicine, prolonged illnesses, and protracted treatments associated with lung diseases in children and adults is further expected to drive the market growth.
Capnography devices are increasingly adopted by physicians and patients for management of respiratory disorders, as these devices facilitate medical intervention in acute as well as chronic patients. The prevalence of respiratory diseases and synergistic effects of obesity, and unhealthy lifestyle, such as smoking, are anticipated to increase. These factors can be further substantiated by a research published in PubMed, which stated that clinicians use these in patients undergoing Patient Controlled Analgesia (PCA) therapy to monitor CO2 levels and avoid chances of an adverse respiratory event.
Capnography Devices Market Competitive Landscape
The companies operating in the capnography devices industry are expanding and developing their product portfolio. For instance, in June 2017, Koninklijke Philips N.V launched IntelliVue X3 in Europe, which is designed for uninterrupted monitoring during in-hospital transport and at the bedside of critical patients. When connected to an IntelliVue bedside monitor, the X3 acts as a multi-measurement module and provides a scalable set of measurements including ECG parameters and in-built carbon dioxide (capnography), and dual invasive pressure.
Similarly, in February 2017, Masimo corporation announced U.S. Food and Drug Administration (USFDA) clearance and worldwide release of the full family of NomoLine capnography sampling lines. The company also mentioned that NomoLine sampling lines were made available in more than 40 configurations of airway adapter sets and cannulas for use in various clinical scenario, in all patient population.
Some of the other key players operating in the capnography devices industry are Diamedica (UK) Limited, Shenzhen Comen Medical Instruments Co. Ltd., Edan Instruments Inc., Nonin Medical Inc., Drägerwerk AG & Co. KGaA, Nihon Kohden Corporation, Medtronic plc, Smiths Group plc, and Becton, Dickinson and Company.